GFI #256

GFI #256

Boothwyn Pharmacy is committed to staying current on all FDA standards and guidelines. Our experts help make the ordering process easy with GFI-256 so you can focus on patient care.

Frequently Asked Questions

When You Prescribe a Compounded Drug For Office Stock, You Should Also:

  • Confirm that the BDS is on the approved List of Bulk Drug Substances for Compounding Office Stock Drugs for Use in Nonfood-Producing Animals or the list of Bulk Drug Substances Currently Under Review.
  • Use the compounded office stock to treat the species of animals under the conditions identified for the BDS on the list.
  • Drugs NOT on this approved list must be tied to a patient-specific prescription when compounded.

Note: If you would like the FDA to consider adding other drugs to the list, you can nominate a BDS at any time by following the directions in the Appendix of the GFI #256. Or, see Nominating a Bulk Drug Substance (BDS) to a List: A Quick Reference.

Questions? We’re Here to Help.

Connect with our team to learn more about our services, resources, and partnership opportunities.

Contact Us